Submitted by Anonymous (not verified) on 15 January 2025 - 14:42
Orphan designation: propagermanium Treatment of focal segmental glomerulosclerosis, 19/11/2018 Withdrawn
Source:
Orphan designation: propagermanium Treatment of focal segmental glomerulosclerosis, 19/11/2018 Withdrawn